Income Statement
ROIVANT SCIENCES LTD.
ROIV
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Mar 31, 2025 2024 FY | Mar 31, 2024 2023 FY | Mar 31, 2023 2022 FY | Mar 31, 2022 2021 FY |
|---|---|---|---|---|
|
Revenue
|
29.05 | 124.80 | 61.28 | 55.29 |
|
Cost of Revenue
|
- | - | - | - |
|
Gross Profit
|
29.05 | 124.80 | 61.28 | 55.29 |
|
Operating Expenses
|
1,142.73 | 1,231.19 | 1,236.60 | 1,406.93 |
|
Research & Development
|
550.41 | 501.74 | 525.22 | 483.04 |
|
Selling, General & Administrative
|
591.41 | 687.44 | 600.51 | 775.03 |
|
Other Operating Expenses
|
- | - | - | - |
|
Operating Income
|
-1,113.68 | -1,106.39 | -1,175.32 | -1,351.64 |
|
Non-Operating Income
|
-432.09 | -5,359.82 | 49.52 | -427.90 |
|
Interest Income
|
258.38 | 146.43 | 32.18 | 0.37 |
|
Interest Expense
|
- | 34.78 | 27.97 | 7.04 |
|
Other Non-Op Income / Expense
|
-10.72 | -6.09 | 15.81 | 0.00 |
|
Income Before Tax
|
0.24 | 5,181.19 | -3.76 | 390.83 |
|
Income Tax Expense
|
-509.61 | -95.50 | -215.80 | -78.49 |
|
Non-Controlling Interest
|
-184.75 | -117.72 | -106.43 | -78.85 |
|
Net Income
|
-171.98 | 4,348.93 | -1,009.03 | -845.26 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Mar 31, 2025 2024 FY | Mar 31, 2024 2023 FY | Mar 31, 2023 2022 FY | Mar 31, 2022 2021 FY |
|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - |
|
EBITDA
|
-1,099.61 | -1,084.36 | -1,156.46 | -1,351.64 |
|
Earnings Per Share (Basic)
|
-0.24 | 5.55 | -1.42 | - |
|
Diluted EPS
|
-0.24 | 5.23 | -1.42 | - |
|
Weighted Average Shares
|
725.40 | 783.25 | 712.79 | - |
|
Diluted Weighted Avg Shares
|
725.40 | 831.05 | 712.79 | - |
|
Comprehensive Income
|
-158.46 | 4,347.46 | -1,010.70 | -847.65 |